Correlation Between Mangalam Drugs and Indraprastha Medical

Can any of the company-specific risk be diversified away by investing in both Mangalam Drugs and Indraprastha Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mangalam Drugs and Indraprastha Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mangalam Drugs And and Indraprastha Medical, you can compare the effects of market volatilities on Mangalam Drugs and Indraprastha Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangalam Drugs with a short position of Indraprastha Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangalam Drugs and Indraprastha Medical.

Diversification Opportunities for Mangalam Drugs and Indraprastha Medical

0.4

Correlation Coefficient

Mangalam Drugs  Indraprastha Medical

Very weak diversification

The 3 months correlation between Mangalam and Indraprastha is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Mangalam Drugs And and Indraprastha Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indraprastha Medical and Mangalam Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangalam Drugs And are associated (or correlated) with Indraprastha Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indraprastha Medical has no effect on the direction of Mangalam Drugs i.e., Mangalam Drugs and Indraprastha Medical go up and down completely randomly.

Pair Corralation between Mangalam Drugs and Indraprastha Medical

Assuming the 90 days trading horizon Mangalam Drugs And is expected to under-perform the Indraprastha Medical. But the stock apears to be less risky and, when comparing its historical volatility, Mangalam Drugs And is 1.12 times less risky than Indraprastha Medical. The stock trades about -0.03 of its potential returns per unit of risk. The Indraprastha Medical is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  43,435  in Indraprastha Medical on September 3, 2024 and sell it today you would earn a total of  2,540  from holding Indraprastha Medical or generate 5.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Mangalam Drugs And  vs.  Indraprastha Medical

Mangalam Drugs And

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mangalam Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Mangalam Drugs is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Indraprastha Medical

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Indraprastha Medical are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain fundamental indicators, Indraprastha Medical may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Mangalam Drugs and Indraprastha Medical

The main advantage of trading using opposite Mangalam Drugs and Indraprastha Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangalam Drugs position performs unexpectedly, Indraprastha Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indraprastha Medical will offset losses from the drop in Indraprastha Medical's long position.

The idea behind Mangalam Drugs And and Indraprastha Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.